Moreover, we could not demonstrate any association of the other nine AGPAT6 variants with these traits of obesity, dyslipidemia, insulin sensitivity or insulin secretion (Additional file 1: Tables S3–11). This evidence concerns the gene INS and metabolic syndrome.